Correct. It can be part of a cocktail of treatments so there is no opportunity cost either. But it seems like monoclonal antibodies are the best option if one m

Correct. It can be part of a cocktail of treatments so there is no opportunity cost either. But it seems like monoclonal antibodies are the best option if one must choose. Ivermectin has not been too impressive in recent research. But research has gone stupid over politics this past year so it’s hard to trust the so called experts at this point. Even if the research is good things are spun by medical pundits with ego in the game.